<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191126045510N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-01-26</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of inter maxillary fixation’s impact on skeletal relapse after mandibular advancement surgery</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of intermaxillary fixation’s impact on skeletal relapse after mandibular advancement surgery:A randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-02-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>56</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/43993</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: We select patients who have undergone preoperative orthodontics and they require 5-10 mm advancment mandibular orthodontic surgery. All samples are coded and arranged. After coding the samples  we use a random number table to divide all samples in two groups. by moving in a row in table only the numbers smaller than the total number of samples are selected. Each  samples with the same  numbers  is selected and is placed in the first group. we would continue this process until the half of samples is allocated in the first group. all other samples is assigned to the second group. The first group was selected as code one and the second group as number two. finally an other random number is selected in the table. if the number is odd the first group would be treated with intermaxillary fixation and if the number is even the second group would be treated as such. The non selected group would be treated with elastic therapy respectively.</study_design>
      <phase>N/A</phase>
      <hc_freetext>subjects  in this study were patients with mandibular hypoplasia..</hc_freetext>
      <i_freetext>Intervention 1: control group: skeletal class II patents with 5 -10 mm skeletal discrepancy undergo mandibular advancement orthognathic surgery with bilateral sagittal split osteotomy with Dalpont's technique. after ward they would receive elastic therapy with  medium force class II (4.5 Oz). in each side of patients mouth medium force elastic would be inserted from mandiular premolars to maxillary canins and from mandibular first molars to maxillary second premolars. Intervention 2: Intervention group: Intervention group:  skeletal class II patents with 5 -10 mm skeletal discrepancy undergo mandibular advancement orthognathic surgery with bilateral sagittal split osteotomy with Dalpont's technique. after ward they would receive inter maxillary fixation for 6 weeks with 28 guages wire brackets.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
all cephalometric  analysis data would be available for other researchers if needed.

When:
starting 6 mounths after publication

To whom:
people working in academic institutions

Conditions:
there is no limitation for analysis of data

Where to obtain:
Contact with Tabmed@gmail.com or +989124473239

How to obtain:
All verified researchers could receive cephalometric analysis after ascertainment of privacy of patients. they could receive data with an email.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>reza tabrizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Dentistry, Daneshjoo Blvd, Evin, Shahid Chamran Highway</address>
        <city>tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983963113</zip>
        <telephone>+98 21 2240 3075</telephone>
        <email>rtabrizi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Reza Tabrizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Dentistry, Daneshjoo Blvd, Evin, Shahid Chamran Highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983969411</zip>
        <telephone>+98 21 2217 5350</telephone>
        <email>rtabrizi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>patients with skeletal class II requiring mandibular advancement surgery (5 -10 mm advancement)
patients with completed presurgical orthodontic treatment
patients with postpubertal skeletal maturity</inclusion_criteria>
      <agemin>17 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>patients who had synchronized maxillary orthognatic surgery
patients with poorly controlled systematic disease such as diabetes melitus, etc.
patients with previous anti resorptive drug such bisposphonates, etc.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M26.04</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Mandibular hypoplasia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>control group: skeletal class II patents with 5 -10 mm skeletal discrepancy undergo mandibular advancement orthognathic surgery with bilateral sagittal split osteotomy with Dalpont's technique. after ward they would receive elastic therapy with  medium force class II (4.5 Oz). in each side of patients mouth medium force elastic would be inserted from mandiular premolars to maxillary canins and from mandibular first molars to maxillary second premolars.</i_keyword>
      <i_keyword>Intervention group: Intervention group:  skeletal class II patents with 5 -10 mm skeletal discrepancy undergo mandibular advancement orthognathic surgery with bilateral sagittal split osteotomy with Dalpont's technique. after ward they would receive inter maxillary fixation for 6 weeks with 28 guages wire brackets.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Me- y axis: It is  the distance between Menthon and Y-Axis on cephalogram. Timepoint: It is evaluated in three time periods: before intervention (T0), one week after intervention (T1) and one year after intervention (T2). Method of measurement: it would be evaluated by standard metallic ruler based on distance between cephalometric reference points on lateral cephalograms.</prim_outcome>
      <prim_outcome>B-Y axis: It is  the distance between B point and Y-Axis on cephalogram. Timepoint: It is evaluated in three time periods: before intervention (T0), one week after intervention (T1) and one year after intervention (T2). Method of measurement: it would be evaluated by standard metallic ruler based on distance between cephalometric reference points on lateral cephalograms.</prim_outcome>
      <prim_outcome>Pog -Y axis: It is the distance between Pog and Y-Axis on cephalom. Timepoint: It is evaluated in three time periods: before intervention (T0), one week after intervention (T1) and one year after intervention (T2). Method of measurement: it would be evaluated by standard metallic ruler based on distance between cephalometric reference points on lateral cephalograms.</prim_outcome>
      <prim_outcome>Me- X axis: It is the distance between Menthon and X-Axis on cephalogram. Timepoint: It is evaluated in three time periods: before intervention (T0), one week after intervention (T1) and one year after intervention (T2). Method of measurement: it would be evaluated by standard metallic ruler based on distance between cephalometric reference points on lateral cephalograms.</prim_outcome>
      <prim_outcome>B-X axis: It is  the distance between B point and X-Axis on cephalogram. Timepoint: It is evaluated in three time periods: before intervention (T0), one week after intervention (T1) and one year after intervention (T2). Method of measurement: it would be evaluated by standard metallic ruler based on distance between cephalometric reference points on lateral cephalograms.</prim_outcome>
      <prim_outcome>Pog -X axis: It is the distance between Pog and X-Axis on cephalogram. Timepoint: It is evaluated in three time periods: before intervention (T0), one week after intervention (T1) and one year after intervention (T2). Method of measurement: it would be evaluated by standard metallic ruler based on distance between cephalometric reference points on lateral cephalograms.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid beheshti university of medical sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-07-03</approval_date>
        <contact_name>Iran National committee for ethics in biomedical research</contact_name>
        <contact_address>7th Floor, Bldg No.2 SBUMS, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
